-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VuwiTLGMNJhyaS6ZONOFfS59G+6Zmqmso7mNZtkgrhgRxsmB868j6BHLpUd3uXaX UYf5rZnyWLjxYSs4IZWrAQ== 0001179110-09-011746.txt : 20090807 0001179110-09-011746.hdr.sgml : 20090807 20090807144122 ACCESSION NUMBER: 0001179110-09-011746 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090806 FILED AS OF DATE: 20090807 DATE AS OF CHANGE: 20090807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNTA PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001157601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 45 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-274-8200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chen Lan Bo CENTRAL INDEX KEY: 0001325711 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33277 FILM NUMBER: 09995003 MAIL ADDRESS: STREET 1: C/O SYNTA PHARMACEUTICALS CORP. STREET 2: 45 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 edgar.xml FORM 4 - X0303 4 2009-08-06 0 0001157601 SYNTA PHARMACEUTICALS CORP SNTA 0001325711 Chen Lan Bo 184 EAST EMERSON ROAD LEXINGTON MA 02420 1 0 1 0 Common Stock 2009-08-06 4 P 0 20000 2.88 A 620035 D Common Stock 12710 I By Alexander Chen Wu 2002 Irrevocable Trust Common Stock 8560 I By Allison Chen Wu 2004 Irrevocable Trust Common Stock 1684016 I By Wisteria Trust Common Stock 243481 I By Ann Chen Trust Common Stock 243481 I By Jane Chen Trust Common Stock 12946 I By Chen Grandchildren's Trust Common Stock 142223 I By LAJ Holdings LLC Common Stock 160000 I By Lan Bo Chen 2008 GRAT Common Stock 320000 I By Lin-Huey Chen 2008 GRAT The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuinary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. /s/ Ann Margaret Eames, Attorney-in-Fact 2009-08-07 -----END PRIVACY-ENHANCED MESSAGE-----